Citicoline

Cholinergic · C14H26N4O11P2 · 488.32 g/mol · CAS 987-78-0

Citicoline (CDP-choline) is a unique choline source that also donates cytidine, supporting both acetylcholine production and the long-term health of neuronal membranes.

Mechanism of Action

When you ingest citicoline, it splits in the intestine into choline and cytidine, both of which independently cross the blood-brain barrier. The choline is used to make acetylcholine and phosphatidylcholine; the cytidine converts to uridine, which is incorporated into neuronal membrane phospholipids and supports dopamine D2 receptor density. The net effect is a slower, more structural cognitive benefit on top of the immediate acetylcholine boost.

Benefits

Typical Dose

250-500mg per serving. Cognizin® branded citicoline is the form used in most peer-reviewed trials.

Safety

Citicoline has an excellent safety profile across decades of clinical use, including in stroke recovery patients. Side effects are rare and typically limited to mild GI upset.

Plopii Products with Citicoline

Focus PouchesEnergy Drinks

FAQ

Should I take citicoline or Alpha-GPC?

Alpha-GPC tends to act faster and feels more acute; citicoline has a more sustained, structural effect and the bonus uridine pathway. Many high-end nootropic stacks (including Plopii Focus Pouches) include both.

Is Cognizin® the same as citicoline?

Cognizin® is a branded, patented form of citicoline manufactured by Kyowa Hakko. The active molecule is identical to generic citicoline but Cognizin® is the form used in most published clinical trials.

Can citicoline replace coffee?

Citicoline is not a stimulant. It supports the systems that stimulants tax. The strongest cognitive effect is achieved by stacking citicoline with a moderate dose of paraxanthine or caffeine.

Peer-Reviewed Citations

  1. McGlade E, Locatelli A, Hardy J, et al. (2012). Improved Attentional Performance Following Citicoline Administration in Healthy Adult Women. Food and Nutrition Sciences 3(6):769-773.
  2. Silveri MM, Dikan J, Ross AJ, et al. (2008). Citicoline Enhances Frontal Lobe Bioenergetics as Measured by Phosphorus MRS. NMR in Biomedicine 21(10):1066-75.
  3. Davalos A, Castillo J, Alvarez-Sabin J, et al. (2002). Oral Citicoline in Acute Ischemic Stroke: Pooled Analysis. Stroke 33(12):2850-7.

These statements have not been evaluated by the FDA. Plopii products are not intended to diagnose, treat, cure, or prevent any disease.